Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FPJHN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,792
Award facts
- Contract value 100% obligated
- $12,792.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,792.31 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with completion expected by July 24, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in the open market based on its small business status and established capability.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and effective through November 2026. The IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment medication, represents one of many prescription pharmaceutical products the vendor supplies through this indefinite delivery vehicle, demonstrating DMS Pharmaceutical Group's critical role in the federal pharmaceutical supply chain serving military health systems.
Quick answers
Who was awarded contract SPE2DB25FPJHN?
SPE2DB25FPJHN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FPJHN worth?
The government has obligated $12,792 on SPE2DB25FPJHN.
Is contract SPE2DB25FPJHN an order under another contract?
Yes. SPE2DB25FPJHN is a delivery order under SPE2DB25D9337, an indefinite delivery contract.
Was contract SPE2DB25FPJHN competed?
The extent of competition for SPE2DB25FPJHN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award